Cargando…
P11 Evaluation of in vitro activity of double β-lactam ‘therapy’ in Escherichia coli: what is the association between ‘synergy’ and in vitro susceptibility?
BACKGROUND: Emerging antimicrobial resistance is a leading cause of patient morbidity/mortality worldwide. A potential strategy in the treatment of resistant infections is the use of combination antibiotics, with the hope of achieving greater in vitro activity, including synergy. It is currently ass...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266169/ http://dx.doi.org/10.1093/jacamr/dlad066.015 |